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Background: Identification of causes of dementia soon after symptom onset is important, because appropriate
treatment of some causes of dementia can slow or halt its progression or enable symptomatic treatment where
appropriate. The accuracy of MRI and CT, and whether MRI is superior to CT, in detecting a vascular component to
dementia in autopsy confirmed and clinical cohorts of patients with VaD, combined AD and VaD (“mixed
dementia”), and AD remain unclear. We conducted a systematic review and meta-analysis to investigate this
question.
Methods: We searched eight databases and screened reference lists to identify studies addressing the review
question. We assessed study quality using QUADAS. We estimated summary diagnostic accuracy according to
imaging finding, and ratios of diagnostic odds ratios (RDORs) for MRI versus CT and high versus low risk of bias.
Results: We included 7 autopsy and 31 non-autopsy studies. There was little evidence that selective patient
enrolment and risk of incorporation bias impacted on diagnostic accuracy (p = 0.12 to 0.95). The most widely
reported imaging finding was white matter hyperintensities. For CT (11 studies) summary sensitivity and specificity
were 71% (95% CI 53%-85%) and 55% (44%-66%). Corresponding figures for MRI (6 studies) were 95% (87%-98%)
and 26% (12%-50%). General infarcts was the most specific imaging finding on MRI (96%; 95% CI 94%-97%) and CT
(96%; 93%-98%). However, sensitivity was low for both MRI (53%; 36%-70%) and CT (52%; 22% to 80%). No imaging
finding had consistently high sensitivity. Based on non-autopsy studies, MRI was more accurate than CT for six of
seven imaging findings, but confidence intervals were wide.
Conclusion: There is insufficient evidence to suggest that MRI is superior to CT with respect to identifying
cerebrovascular changes in autopsy-confirmed and clinical cohorts of VaD, AD, and ‘mixed dementia’.
Keywords: Dementia, CT, MRI, Diagnosis, Systematic reviewBackground
Dementia can be caused by different pathological pro-
cesses that are often difficult to distinguish clinically, par-
ticularly in the early stages of the condition. Alzheimer’s
disease (AD) is the most frequent, followed by vascular
dementia (VaD), mixed pathology and dementia with
Lewy Bodies [1]. Identification of causes of dementia
soon after symptom onset is critical, because appropriate* Correspondence: penny.whiting@bristol.ac.uk
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reproduction in any medium, provided the ortreatment of some causes of dementia can slow or halt
its progression or enable symptomatic treatment where
appropriate [2]. Acetylcholinesterase inhibitors may im-
prove symptoms of Alzheimer’s disease, while dementia
with a vascular pathology can be treated by addressing
the vascular risk factors e.g. prescribing low dose aspirin
or similar medication [3]. Failure to distinguish VaD from
AD may lead to inappropriate treatment.
Autopsy is the reference standard for differential diag-
nosis of dementia in a research context. In clinical prac-
tice, and in research that does not follow patients until
death, diagnostic criteria consisting of a combination ofl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and imaging findings are often used. These include the
National Institute of Neurological Disorders and Stroke
and Association Internationale pour la Recherche et
l’Ensignement en Neurosciences (NINDS-AIREN) cri-
teria for VaD [4] and the National Institute of Neuro-
logical and Communicative Disorders and Stroke and
the Alzheimer's Disease and Related Disorders Associ-
ation (NINCDS-ADRDA) criteria for AD [5]. Neuroima-
ging is increasingly regarded as an essential part of the
diagnostic work-up of a patient with dementia. Magnetic
Resonance Imaging (MRI) has been advocated as the
preferred imaging method in clinical guidelines [6], des-
pite being more costly and (in some health systems) less
readily available than computed tomography (CT).
Previously, neuroimaging was used to exclude abnor-
malities such as normal pressure hydrocephalus,
tumours and subdural hematoma [7], but it is increas-
ingly used to identify features consistent with the path-
ology of dementia subtypes such as cerebrovascular
changes. The accuracy of MRI and CT, and whether
MRI is superior to CT, in detecting a vascular compo-
nent to dementia in clinical cohorts of patients with
VaD, combined AD and VaD (“mixed dementia”), and
AD remain unclear. We conducted a systematic review
and meta-analysis to investigate this question.
Methods
We produced a protocol for the review (available from
the authors on request) detailing the proposed review
methods.
Literature search
We searched MEDLINE, EMBASE, BIOSIS, Science
Citation Index, ZETOC, NTIS, Dissertation Abstracts,
and the GrayLit networkfrom database inception to Feb-
ruary 2011 for published and unpublished studies. We
combined terms for each imaging test (Magnetic Reson-
ance Imaging” OR “mri” OR “Computed Tomography”
OR “ct scan$”) with terms for the target conditions (“Alz-
heimer Disease” OR “Vascular Dementia” OR “multi-in-
farct dementia”). We did not use a methodological
search filter to identify diagnostic accuracy studies, be-
cause such filters may result in omission of relevant stud-
ies [8,9]. No language restrictions were applied.
Study selection
Studies that assessed the accuracy of MRI and/or CT
(index tests) for the detection of cerebrovascular changes
in patients with VaD, AD or mixed dementia (target con-
ditions) against an appropriate reference standard were
eligible for inclusion. Eligible reference standards for
VaD and AD included: autopsy; NINCDS-ADRDA [5]
for AD; NINDS-AIREN [4] for VaD; Diagnostic andStatistical Manual of Mental Disorders (DSM) DSM-III
[10], DSM-III R [11], DSM-IV [12]; State of California
AD Diagnostic and Treatment Centre Criteria (ADDTC)
[13]; and ICD-10 [14]. Any reported reference standard
for mixed dementia was eligible. All subtypes of VaD (e.
g. multi-infarct dementia; subcortical vascular ischemic
dementia; and Binswanger’s dementia) were included in
the VaD group. Studies had to report 2x2 performance
data for one or more of the following cerebrovascular
imaging findings: general infarcts; lacunar infarcts; non-
lacunar infarcts; white matter hyperintensities (WMH);
periventricular hyperintensities (PVH); basal ganglia
hyperintensities (BGH); or a ‘global assessment’ finding,
such as the presence of two or more findings. Two
reviewers independently screened titles and abstracts.
Full papers were assessed by one reviewer and checked
by another; disagreements were resolved through con-
sensus or referral to the review team.
Data extraction and quality assessment
Data extraction and quality assessment were completed
by one reviewer and checked by a second; disagreements
were resolved through discussion or referral to a third
reviewer. We extracted data on: inclusion/exclusion cri-
teria, included patients, CT and MRI technical and oper-
ator details, reference standard, imaging finding,
definition of a positive imaging finding, numbers of
patients in each patient group (VaD, mixed dementia,
AD or other diagnosis), and number of patients with
positive imaging findings in each group. The patient
groups were dichotomised as VaD or mixed dementia
compared to AD or other diagnoses. This allowed con-
struction of 2x2 tables of test performance, separately
for each imaging finding assessed. Study quality was
assessed using the Cochrane Collaboration’s adaption of
the QUADAS tool [15].
Statistical analyses
We calculated sensitivity, specificity, and the diagnostic
odds ratio (DOR) of MRI and CT for the detection of
VaD or Mixed dementia, for each 2x2 table. We plotted
estimates of sensitivity and specificity from individual
studies in summary receiver operating characteristic
(SROC) space, separately for each imaging finding. We
conducted separate analyses for studies that did and did
not use autopsy as the reference standard. Summary sen-
sitivity and specificity were estimated using the bivariate/
HSROC meta-analysis models when sufficiently many
studies (usually at least four) reported on the same im-
aging finding [16]. If too few studies were available to
permit use of these models (for example, because the es-
timation procedure did not converge), univariate ran-
dom-effects meta-analysis was carried out. We
investigated the utility of different MRI and CT imaging
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mixed dementia, by deriving positive and negative likeli-
hood ratios from summary estimates of sensitivity and
specificity. We used standard random-effects meta-
analysis [17] to estimate summary DORs for each im-
aging finding, separately for MRI and CT, and then used
meta-regression to calculate ratios of DORs (RDORs)
comparing MRI with CT. We also estimated RDORs
comparing MRI and CT in studies that reported direct
comparisons of the two techniques. Estimates of the
between-study variance τ2 were used to quantify hetero-
geneity. There were insufficient included studies to allow
assessment of reporting bias.
We assessed the impact of patient spectrum (QUA-
DAS item 1) and incorporation bias (QUADAS item 6)
on diagnostic accuracy using meta-regression to calcu-
late ratios of RDORs comparing the DOR in studies that
were rated “no” or “unclear” with those rated “yes” on
these QUADAS items, separately for MRI and CT. In
these analyses, we selected one set of 2x2 data from each
study on the basis of the following hierarchy: (1) global
assessment, (2) white matter hyperintensities, (3) lacunar
infarcts, (4) periventricular hyperintensities, (5) any
other imaging finding. All analyses were done using
Stata™ version 11, using the metan, metandi and metareg
commands [18-20].
Results
The searches identified 19,669 titles and abstracts; 38
studies (4377 patients, range 23 to 683) were included in19,669 hits in medi
literature database
38 studies included in
4 assessed both MRI a12 assessed MRI only
573 included on title 
abstract
Figure 1 Flowchart of systematic review process.the review (Figure 1). Twenty-six studies (37 sets of 2x2
data) assessed CT, 16 (33 sets of 2x2 data) assessed MRI;
4 evaluated both CT and MRI and thus provided direct
comparisons between the two techniques. Twenty stud-
ies were prospective cohorts, 6 were retrospective
cohorts and 12 were case–control studies Table 1. Publi-
cation dates ranged from 1986 to 2010.
Seven studies used autopsy as reference standard; all
others used clinical criteria with or without imaging find-
ings. VAD was confirmed by NINDS-AIREN (13 studies),
DSM-III or DSM-III-R (16), and ICD10 (1). Reference
standards used to define AD were NINCDS-ADRA (24
studies), DSM-III or DSM-III-R (6) and ICD10 (1). Six
studies included mixed dementia patients, 2 used DSM-
III-R, 2 used ADDTC, 1 ICD10, 1 Hachinski Ischemic
Score and 1 history and examination as reference stand-
ard. Mean age, where reported, ranged from 66 years to
85 years and was generally higher in autopsy than non-
autopsy studies. Individual study demographics and
results are shown in the Additional file 1.
The main limitations of the included studies were the
potential for biased selection of patients and incorpor-
ation bias. Most studies (61%) did not enrol an appropri-
ate patient spectrum, defined as patients with suspected
dementia in whom the diagnosis had not been con-
firmed. There was a risk of incorporation bias in 23
(61%) of the non-autopsy studies, because the reference
standard included the imaging findings. Other QUADAS
items were classified as adequate or unclear in the ma-
jority of studies (Figure 2).cal 
s
 review
22 assessed CT onlynd CT
535 Full papers excluded (papers can 
be excluded for multiple reasons): 
Not diagnostic accuracy study: 78
Did not assess MRI or CT: 245
No reference standard: 74
Did not assess VaD or mixed 
dementia : 53
Unable to derive 2x2 data: 44
Did not assess imaging findings of 
interest : 32
Did not use an accepted reference 
standard: 7
Exact duplicate: 2
19,096 excluded on title and abstract
and 
Table 1 Number of studies assessing each imaging
method, according to study design and reference
standard
MRI only CT only MRI and CT Total
Study Design
Prospective cohort 4 14 2 20
Retrospective cohort 1 4 1 6
Case-control 7 4 1 12
Reference standard
Autopsy 1 6 0 7
Non-autopsy 11 16 4 31
Total 12 22 4 38
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There was substantial variation in estimates of accuracy
reported in individual studies (Additional file 1). Figure 3
shows individual study estimates plotted in SROC space,
separately for each imaging finding with different sym-
bols according to imaging method (MRI or CT) and
reference standard (autopsy or non-autopsy). These fig-
ures suggest that autopsy studies produced more of the
outlying studies than the non-autopsy studies although
there was no clear association with either sensitivity or
specificity. Data from both direct and indirect compari-
sons suggested that MRI was more specific than CT
with variable effects on sensitivity. The most specific im-
aging finding on both MRI and CT was general infarcts,
but sensitivity was very heterogeneous for this finding.
Non-lacunar infarcts also showed reasonable specificity,
with heterogenous sensitivity. None of the findings had
consistently high sensitivity. The most sensitive imaging
finding appeared to be basal ganglia hyperintensities, but
specificity was more variable and this finding was only
assessed in five studies. White matter hyperintensities0%
Uninterpretable imaging results reported
Same clinical data available as real world situation
Reference standard results blinded to imaging
Imaging results blinded to reference standard
Reference standard independent of imaging
Same reference standard
Whole/random sample verification
Autopsy reference standard
Acceptable time between imaging & reference …
Spectrum composed of suspected dementia …
QU
AD
AS
 It
em
Figure 2 Proportions of studies rated as ’yes”, “no” or “unclear” for ewas the most commonly assessed finding, but results
were heterogeneous.
Autopsy studies
Six autopsy studies assessed CT and one assessed MRI
(Table 2). White matter hyperintensities was the only
imaging finding assessed on both MRI and CT; none of
the studies reported a direct comparison between the
two techniques. Based on three studies assessing white
matter hyperintensities, the RDOR comparing CT (n = 2)
with MRI (n = 1) was 0.28 (95% CI 0 to 55849), p = 0.42.
Non-autopsy studies
We compared the DORs in studies that incorporated
imaging findings in the reference standard with those
that did not, and in studies that enrolled a selected sam-
ple of patients with those did not (Table 3). Each study
contributed one set of 2 × 2 data to these analyses, based
on the hierarchy described earlier. There was weak evi-
dence that the accuracy of CT was overestimated in
studies in which incorporation bias was present (RDOR
3.97, 95% CI 0.68 to 23.2) (p = 0.12). There was little evi-
dence for an association between incorporation bias and
MRI (p = 0.88), or between biased selection of patients
and CT (p = 0.95) or MRI (p = 0.21). Based on these find-
ings, we did not exclude studies with limitations in pa-
tient selection or at risk of incorporation bias from
subsequent analyses.
Table 4 shows summary estimates of sensitivity, speci-
ficity and positive and negative likelihood ratios for each
imaging method and finding. Neither the individual im-
aging findings, nor the global assessment criteria, were
found to have consistently high sensitivity. The most
widely reported imaging finding was white matter hyper-
intensities. For CT (11 studies) summary sensitivity and
specificity were 71% (95% CI 53% to 85%) and 55%20% 40% 60% 80% 100%
Percentage of studies
yes
no
unclear
ach QUADAS item.
Studies with non-autopsy reference standard Studies with autopsy reference standard
CT MRI CT MRI
Global assessment Basal ganglia hyperintensities 
White-matter hyperintensities/changes Lacunar infarcts 
Periventricular hyperintensities Non-lacunar infarcts 
General infarcts 
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Figure 3 Summary ROC plots showing imaging findings from individual studies, according to imaging method and reference standard.
Solid lines join MRI and CT results from the same study (direct comparisons).
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(6 studies) were 95% (95% CI 87% to 98%) and 26%
(95% CI 12% to 50%). This finding therefore had lim-
ited utility in ruling in or ruling out a diagnosis of VaD
or mixed dementia. General infarcts was the most spe-
cific imaging finding on both MRI (96% (95% CI 94%
to 97%)) and CT (96% (95% CI 93% to 98%)) with little
heterogeneity (tau2 = 0). Corresponding positive likeli-
hood ratios were also relatively high (LR + 13.08 (95%CI 7.64 to 22.4) for MRI and 12.22 (95% CI 5.59 to
26.7) for CT). However, sensitivity was low and showed
substantial heterogeneity for both MRI (53% (95% CI
36% to 70%); tau2 = 0.21) and CT (52% (95% CI 22% to
80%), tau2 = 1.66).
MRI was found to have greater accuracy than CT for
six of the seven imaging findings assessed (Table 5) with
RDORs ranging from 1.78 (95% CI 0.11, 28.2) for peri-
ventricular hyperintensities to 2.68 (95% CI 0.33 to
Table 2 Summary estimates of diagnostic accuracy from autopsy studies, according to imaging finding and method
Imaging finding Number
of studies
Sample
size
Sensitivity
(95% CI)
tau2 for
sensitivity
Specificity
(95% CI)
tau2 for
specificity
Positive
likelihood
ratio (95% CI)
Negative
likelihood
ratio (95% CI)
DOR (95%
CI)
CT
White matter
hyperintensities
2 84 73 (58, 84) 0 63 (46, 77) 0 1.96 (1.23, 3.12) 0.43 (0.25, 0.75) 4.5 (1.70, 12)
Global
assessment
1 32 18 (6, 41) — 80 (55, 93) — 0.88 (0.21, 3.73) 1.03 (0.74, 1.44) 0.9 (0.20, 4.50)
Periventricular
hyperintensities
3 31 85 (43, 98) 1.95 50 (11, 89) 2.12 1.70 (0.58, 5.05) 0.30 (0.04, 2.18) 5.6 (0.32, 100)
Lacunar
infarcts
1 96 12 (4, 29) — 100 (57, 100) — 1.40 (0.08, 23.74) 0.96 (0.73, 1.27) ∞ (0.14, ∞)
Non-lacunar
infarcts
2 79 70 (56, 81) 0 93 (80, 99) 0 12.75 (3.28, 49.60) 0.31 (0.20,0.48) 41 (8.20, 196)
General infarcts 2 123 41 (5, 89) 2.8 78 (32, 96) 1.7 1.82 (0.22,15.20) 0.76 (0.25,2.30) 2.4 (0.10, 57)
MRI
White matter
hyperintensities
1 43 79 (52, 92) — 28 (15, 46) — 1.09 (0.76, 1.55) 0.78 (0.24, 2.49) 1.4 (0.33, 5.80)
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vals were wide and evidence for an association was
weak (p-values ranged from 0.15 to 0.64). The four
studies that reported direct comparisons of MRI and
CT supported the results from the indirect compari-
sons. However, RDORs were smaller for most imaging
findings (range 1.12 to 1.86) with the exception of one
study of global assessment (RDOR 14.81, 95% CI 1.73
to 127.14) and one of periventricular hyperintensities
(RDOR 5.08, 95% CI 0.46 to 55.70).Table 3 Comparisons of diagnostic odds ratios according
to presence or absence of incorporation and selection
bias, for each imaging method
Design feature Imaging method Ratio of diagnostic
odds ratios (95% CI)
p-value
Incorporation bias CT 3.97 (0.68,23.2) 0.12
MRI 0.90 (0.20,3.95) 0.88
Selection bias CT 1.05 (0.20,5.55) 0.95
MRI 0.53 (0.18,1.51) 0.21Discussion
In this systematic review, we searched nearly 20,000
titles and abstracts in order to identify 38 studies that
investigated the diagnostic accuracy of MRI or CT for
detecting a vascular component to dementia. Only four
of these studies assessed both imaging methods.
Included studies were generally small and many were at
high risk of bias due to the potential for biased selection
of patients and possibility that test results were incorpo-
rated into the reference standard. However there was lit-
tle evidence that these sources of bias impacted on
estimates of accuracy. Only seven studies used autopsy
as the reference standard, and their results were hetero-
geneous. Among the 31 studies that used a non-autopsy
reference standard, no individual imaging finding was
assessed in a majority of studies, and results were het-
erogeneous. White matter hyperintensities were the
most frequently assessed imaging finding, but based on
summary estimates of sensitivity and specificity this find-
ing had limited utility for ruling in or ruling out a diag-
nosis of VaD or mixed dementia. The presence of
general infarcts showed the greatest potential for ruling
in a diagnosis of VaD or mixed dementia, but none ofthe findings appeared sufficiently sensitive to rule out a
diagnosis of AD. Comparative analyses suggested that
MRI may be more accurate than CT for distinguishing
vascular or mixed dementia from Alzheimer’s disease
and other conditions, but confidence intervals on esti-
mated ratios of diagnostic odds ratios were wide.
We performed a comprehensive search, without lan-
guage restrictions, to identify both published and unpub-
lished literature: thus it is unlikely that relevant studies
have been missed. We employed systematic review
methods to minimise bias and errors during study selec-
tion, data extraction and quality assessment and used
the most rigorous methods of meta-analysis for diagnos-
tic accuracy data. We made both direct and indirect
comparisons of the accuracy of CT and MRI, but were
limited by the substantial between-study heterogeneity
and small number of studies that directly compared the
imaging methods. We assessed study quality using
accepted criteria for diagnostic accuracy studies and
investigated the effects of potential sources of bias in the
analysis. Most of the included studies did not enrol an
appropriate patient spectrum, which we defined as
patients with symptoms of dementia in whom the
Table 4 Summary estimates of diagnostic accuracy from non-autopsy studies, according to imaging finding and
method
Imaging finding Number
of studies
Sample
size
Sensitivity
(95% CI)
tau2 for
sensitivity
Specificity
(95% CI)
tau2 for
specificity
Positive
likelihood
ratio (95% CI)
Negative
likelihood
ratio (95% CI)
CT
Global
assessment
2 107 62 (50,72) 0.01 94 (1,100) 16.45 9.61 (0.01, 6410) 0.41 (0.24, 0.69)
White matter
hyperintensities
11 196 71 (53,85) 1.53 55 (44,66) 0.48 1.58 (1.26, 1.98) 0.52 (0.32, 0.85)
Periventricular
hyperintensities
3 354 49 (39,59) 0 69 (33,91) 1.48 1.57 (0.55, 4.44) 0.74 (0.45, 1.24)
Lacunar
infarcts
3 667 42 (9,85) 2.93 86 (43,98) 2.74 3.22 (0.34, 30.9) 0.66 (0.27, 1.66)
Non-lacunar
infarcts
2 1900 45 (34,56) 0 80 (68,88) 0.03 2.23 (1.34, 3.70) 0.69 (0.55, 0.87)
General infarcts 4 381 52 (22,80) 1.66 96 (93,98) 0 12.22 (5.59, 26.7) 0.50 (0.25, 1.01)
Basal ganglia
hyperintensities
1 163 86 (78,92) - 38 (28,49) - 1.32 (1.09, 1.60) 0.38 (0.20, 0.73)
MRI
Global
assessment
4 170 69 (36,90) 1.57 86 (45,98) 3.14 4.86 (1.10, 21.5) 0.36 (0.16, 0.80)
White matter
hyperintensities
6 334 95 (87,98) 0.75 26 (12,50) 1.41 1.29 (1.01, 1.66) 0.19 (0.07, 0.48)
Periventricular
hyperintensities
7 315 92 (70,98) 3.61 24 (6,60) 4.45 1.19 (0.88, 1.63) 0.33 (0.10, 1.10)
Lacunar
infarcts
4 599 75 (40,93) 1.82 83 (58,95) 1.45 4.49 (1.87, 10.8) 0.30 (0.11, 0.82)
Non-lacunar
infarcts
4 514 53 (41,65) 0.13 91 (85,95) 0.05 6.11 (3.13, 11.9) 0.52 (0.39, 0.68)
General infarcts 3 955 53 (36,70) 0.21 96 (94,97) 0 13.08 (7.64, 22.4) 0.49 (0.35, 0.71)
Basal ganglia
hyperintensities
4 396 77 (66,85) 0.10 78 (67,86) 0.17 3.46 (2.14, 5.60) 0.29 (0.18, 0.48)
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CT will have most clinical value if used at a relatively
early stage in the diagnostic work-up of patients with
symptoms of dementia, in order to help reach a defini-
tive diagnosis and begin appropriate treatment early in
the course of disease. Studies that did not assess MRITable 5 Summary estimates of diagnostic odds ratios from no
method, and comparison of the diagnostic accuracy of the tw
Imaging finding MRI CT
Number
of studies
Diagnostic odds
ratio (95% CI)
Num
of s
Global assessment 4 9.43 (0.67,132) 2
Lacunar infarcts 4 12.99 (3.02,55.9) 3
Non-lacunar infarcts 4 8.79 (3.20,24.2) 2
General infarcts 3 16.78 (2.01,139) 4
White matter hyperintensities 6 5.98 (1.90,18.9) 11
Periventricular hyperintensities 7 3.83 (0.71,20.6) 3
Basal ganglia hyperintensities 4 10.17 (1.62,63.9) 1and/or CT in this context may produce less applicable,
or biased, estimates of diagnostic accuracy: for example
if they used a case–control design where cases already
have a confirmed diagnosis of dementia subtype, or if
they were conducted in patients with a longer duration
of illness.n-autopsy studies, according to imaging finding and
o methods
Comparison of MRI with CT
ber
tudies
Diagnostic odds
ratio (95% CI)
Ratio of
diagnostic odds
ratios (95% CI)
p-value tau2
3.98 (0.10,160) 2.37 (0.03,222) 0.63 2.17
4.85 (1.06,22.2) 2.68 (0.33,22.0) 0.28 0.65
3.49 (1.27,9.59) 2.52 (0.60,10.5) 0.15 0
29.58 (3.99,219) 0.57 (0.03,10.5) 0.64 1.53
2.79 (1.43,5.44) 2.14 (0.57,8.09) 0.24 0.63
2.15 (0.24,19.3) 1.78 (0.11,28.2) 0.64 1.98
4.06 (0.15,109) 2.50 (0.58,108) 0.50 0.75
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used an autopsy or non-autopsy reference standard. Be-
cause only a small number of autopsy studies were avail-
able, the impact of the type of reference standard on
estimated diagnostic accuracy could not be evaluated
with precision: no more than three autopsy studies
assessed any individual imaging finding and most find-
ings were assessed in only one or two studies. Although
we considered autopsy to be the least biased reference
standard there is a potential risk of disease progression
bias as there will be a time lapse between the imaging
and the autopsy examination. This means that some
patients may not have had VaD orAD when they were
assessed by MRI/CT but have developed one of these
conditions before they died. This has the potential to
impact on estimates of sensitivity and specificity, de-
pending on whether the original reference standard is
more likely to wrongly classify patients as VaD or AD.
There was a risk of bias due to incorporation of test
results in the reference standard, in many studies that
used a non-autopsy reference standard. There was a sug-
gestion that incorporation bias resulted in greater diag-
nostic accuracy for studies of CT but this was not found
for studies of MRI. We would expect incorporation bias
to increase agreement between the index test and refer-
ence standard leading to inflated estimates of sensitivity
and specificity [21].
In the United States, the use of either CT or MRI as
part of the diagnostic work-up of a dementia patient is
recommended [22]. The UK National Institute for
Health and Clinical Excellence (NICE) guidelines on de-
mentia diagnosis state that structural imaging should be
used in the assessment of suspected dementia to exclude
other cerebral pathologies and to help establish the sub-
type diagnosis [6]. MRI is referred to as the preferred
method to detect subcortical vascular changes, although
it is acknowledged that CT could also be used. A 1988
narrative review by Joyce and Lishman [23], which dis-
cussed 9 studies, concluded that neither CT nor MRI
are reliable in the differential diagnosis of AD and VaD.
Both CT and MRI technology have developed consid-
erably in the time since the majority of the included
studies were conducted. For example, helical CT with
multiplanar reconstruction is now routinely used and
has higher image resolution than the CT scans evaluated
in the included studies. Modern CT may be considered
to be preferential to MRI because it is quicker and much
cheaper to buy and run, it is more comfortable for the
patient and there are fewer contraindications to its use.
It can be reconstructed in the coronal plane for direct
visual assessment of hippocampal volume. These factors
should be weighed against increased exposure to ionis-
ing radiation exposure with CT. In the future, fluoro-
deoxyglucose (FDG) - positron emission tomography(PET) may be useful in predicting decline in normal sub-
jects and individuals with mild cognitive impairment
[24]. Abeta-PET appears most useful in distinguishing
AD from other dementias, although it has recently been
suggested that a combination of Abeta- and FDG-PET
may be more accurate. However, neither of these techni-
ques is widely available in many hospital settings [25].
New diagnostic accuracy studies are needed to com-
pare the utility of the latest generation of MRI and CT
techniques in detecting a vascular component to demen-
tia. The design of studies should aim to avoid the weak-
nesses of the studies located for this review. They should
assess both MRI and CT in the same group of patients
with symptoms of early dementia. Study size should be
large enough to allow precise estimates of relative diag-
nostic accuracy. The reference standard should consist of
accepted diagnostic criteria, without incorporating im-
aging findings, ideally supplemented by autopsy confirm-
ation. Global assessment criteria for MRI and CT, based
on the most useful individual imaging findings that are
indicative of a vascular component to dementias, should
be established, and their diagnostic accuracy quantified.Conclusions
This comprehensive, systematic literature review has
shown that, despite its longstanding and widespread use,
there is no strong evidence to suggest that MRI is more
accurate than CT in identifying cerebrovascular changes
in autopsy-confirmed and clinical cohorts of VaD, AD,
and ‘mixed dementia’. There is a need for new, large,
high quality studies comparing state of the art CT with
MRI in patients with symptoms of early dementia.Additional files
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